| scholarly article | Q13442814 |
| P50 | author | Ming Tan | Q115232766 |
| P2093 | author name string | Xi Jiang | |
| P2860 | cites work | Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity | Q40726413 |
| The coat protein of Rabbit hemorrhagic disease virus contains a molecular switch at the N-terminal region facing the inner surface of the capsid. | Q41628578 | ||
| A T = 1 capsid formed by protein of brome mosaic virus in the presence of trypsin | Q44252585 | ||
| The self-assembly of the cowpea strain of southern bean mosaic virus: formation of T = 1 and T = 3 nucleoprotein particles | Q45393115 | ||
| Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals | Q45732225 | ||
| A molecular switch in the capsid protein controls the particle polymorphism in an icosahedral virus | Q45733476 | ||
| The structure of a T = 1 icosahedral empty particle from southern bean mosaic virus | Q45827983 | ||
| E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. | Q54497752 | ||
| Epidemiologic and Molecular Trends of “Norwalk‐like Viruses” Associated with Outbreaks of Gastroenteritis in the United States | Q57661856 | ||
| Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells | Q77602048 | ||
| Cellular and humoral immunity following Snow Mountain virus challenge | Q24556676 | ||
| The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors | Q24563224 | ||
| X-ray crystallographic structure of the Norwalk virus capsid | Q27619935 | ||
| Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16 | Q27625236 | ||
| Human susceptibility and resistance to Norwalk virus infection | Q28190653 | ||
| Proteins of Norwalk virus | Q30414067 | ||
| Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle | Q33341241 | ||
| Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns | Q33788719 | ||
| Tissue distribution of histo-blood group antigens | Q33852459 | ||
| Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis | Q33890198 | ||
| Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice | Q33962224 | ||
| Gastroenteritis viruses: an overview | Q34083383 | ||
| Inter- and intragenus structural variations in caliciviruses and their functional implications | Q34186292 | ||
| Mutations within the P2 Domain of Norovirus Capsid Affect Binding to Human Histo-Blood Group Antigens: Evidence for a Binding Pocket | Q34275858 | ||
| Structural requirements for the assembly of Norwalk virus-like particles | Q34335587 | ||
| ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world | Q34346443 | ||
| Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens | Q34461894 | ||
| Norovirus disease: changing epidemiology and host susceptibility factors | Q35785637 | ||
| Specific proteolytic cleavage of recombinant Norwalk virus capsid protein | Q35834628 | ||
| Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. | Q35869424 | ||
| Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells | Q35896548 | ||
| Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions | Q36510326 | ||
| Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein | Q36685153 | ||
| Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns | Q38353300 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | norovirus | Q1142751 |
| P304 | page(s) | 14017-14030 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors | |
| P478 | volume | 79 |
| Q47151435 | A Bacterial Surface Display System Expressing Cleavable Capsid Proteins of Human Norovirus: A Novel System to Discover Candidate Receptors. |
| Q35683789 | A Unique Human Norovirus Lineage with a Distinct HBGA Binding Interface |
| Q35301295 | A candidate dual vaccine against influenza and noroviruses |
| Q45362011 | A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles |
| Q37716268 | A dual chicken IgY against rotavirus and norovirus |
| Q37502688 | A dual vaccine candidate against norovirus and hepatitis E virus |
| Q39099714 | A single-amino-acid substitution in the P2 domain of VP1 of murine norovirus is sufficient for escape from antibody neutralization |
| Q36519453 | A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus |
| Q64239479 | Active immunization with norovirus P particle-based amyloid-β chimeric protein vaccine induces high titers of anti-Aβ antibodies in mice |
| Q35152899 | Affinities of human histo-blood group antigens for norovirus capsid protein complexes |
| Q34464196 | Affinities of recombinant norovirus P dimers for human blood group antigens |
| Q36350303 | An outbreak caused by GII.17 norovirus with a wide spectrum of HBGA-associated susceptibility |
| Q33316050 | Analysis of amino acid variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-specific epitopes |
| Q37092522 | Animal noroviruses. |
| Q37101808 | Anti-norovirus therapeutics: a patent review (2010-2015). |
| Q35615462 | Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera |
| Q89065119 | Application of a salivary immunoassay in a prospective community study of waterborne infections |
| Q36490501 | Application of salivary antibody immunoassays for the detection of incident infections with Norwalk virus in a group of volunteers |
| Q37651671 | Bacterial Surface-Displayed GII.4 Human Norovirus Capsid Proteins Bound to HBGA-Like Molecules in Romaine Lettuce |
| Q91576751 | Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform |
| Q34064413 | Branched-linear and agglomerate protein polymers as vaccine platforms |
| Q35023707 | C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein. |
| Q40466432 | C-terminal domain on the outer surface of the Macrobrachium rosenbergii nodavirus capsid is required for Sf9 cell binding and internalization. |
| Q64260697 | Changes in norovirus genotype diversity in gastroenteritis outbreaks in Alberta, Canada: 2012-2018 |
| Q40042470 | Characterization of Antigenic Relatedness between GII.4 and GII.17 Noroviruses by Use of Serum Samples from Norovirus-Infected Patients |
| Q37182665 | Characterization of a Novel Conformational GII.4 Norovirus Epitope: Implications for Norovirus-Host Interactions. |
| Q104134097 | Characterization of a hospital-based gastroenteritis outbreak caused by GII.6 norovirus in Jinshan, China |
| Q40623456 | Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability |
| Q37296094 | Comparison of norovirus genogroup I, II and IV seroprevalence among children in the Netherlands, 1963, 1983 and 2006. |
| Q47655608 | Comprehensive characterization of a major capsid protein derived from a documented GII.6 norovirus strain |
| Q21143806 | Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution |
| Q21090777 | Cryo-EM structure of a novel calicivirus, Tulane virus |
| Q35034538 | Crystal structures of GI.8 Boxer virus P dimers in complex with HBGAs, a novel evolutionary path selected by the Lewis epitope |
| Q27671411 | Crystallography of a Lewis-Binding Norovirus, Elucidation of Strain-Specificity to the Polymorphic Human Histo-Blood Group Antigens |
| Q36914794 | Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus |
| Q38480760 | Development of an enzyme immunoassay for detection of sapovirus-specific antibodies and its application in a study of seroprevalence in children |
| Q64231849 | Early Porcine Sapovirus Infection Disrupts Tight Junctions and Uses Occludin as a Coreceptor |
| Q34384013 | Effect of grape seed extract on human norovirus GII.4 and murine norovirus 1 in viral suspensions, on stainless steel discs, and in lettuce wash water |
| Q41134223 | Effects of a variety of food extracts and juices on the specific binding ability of norovirus GII.4 P particles. |
| Q104289416 | Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine |
| Q36415015 | Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. |
| Q39330548 | Emergence of two novel norovirus genotype II.4 variants associated with viral gastroenteritis in China. |
| Q36391936 | Engineering Bacterial Surface Displayed Human Norovirus Capsid Proteins: A Novel System to Explore Interaction Between Norovirus and Ligands. |
| Q40103527 | Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens |
| Q36392947 | Evaluation of anti-norovirus IgY from egg yolk of chickens immunized with norovirus P particles |
| Q40294801 | Exploration of the metal coordination region of concanavalin A for its interaction with human norovirus. |
| Q64104240 | GII.13/21 noroviruses recognize glycans with a terminal β-galactose via an unconventional glycan binding site |
| Q34160482 | Gangliosides are ligands for human noroviruses |
| Q42225298 | Genetic analysis of the capsid region of norovirus GII.4 variants isolated in South Korea |
| Q34120230 | Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008. |
| Q59349118 | Genomic characterization of a RdRp-recombinat nebovirus strain with a novel VP1 genotype |
| Q52760693 | Glycan-specificity of four neuraminidase-sensitive animal rotavirus strains. |
| Q64099047 | Glycopeptides and -Mimetics to Detect, Monitor and Inhibit Bacterial and Viral Infections: Recent Advances and Perspectives |
| Q33614589 | Heterotypic humoral and cellular immune responses following Norwalk virus infection |
| Q36194784 | High Protective Efficacy of Probiotics and Rice Bran against Human Norovirus Infection and Diarrhea in Gnotobiotic Pigs |
| Q30234848 | Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy |
| Q38194256 | Histo-blood group antigens: a common niche for norovirus and rotavirus |
| Q35008592 | Identifying carbohydrate ligands of a norovirus P particle using a catch and release electrospray ionization mass spectrometry assay |
| Q92759295 | Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice |
| Q24810360 | Immunogenetic mechanisms driving norovirus GII.4 antigenic variation |
| Q89845934 | Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine |
| Q28534736 | Inhibition of histo-blood group antigen binding as a novel strategy to block norovirus infections |
| Q34059409 | Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs |
| Q39925244 | Mapping and modeling of a strain-specific epitope in the Norwalk virus capsid inner shell |
| Q28472177 | Mechanisms of GII.4 norovirus persistence in human populations |
| Q36594372 | Mendelian resistance to human norovirus infections |
| Q35156493 | Molecular epidemiology of norovirus in South Korea |
| Q44611786 | Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization. |
| Q36429481 | Noroviral P particle: structure, function and applications in virus-host interaction |
| Q35107678 | Noroviral p-particles as an in vitro model to assess the interactions of noroviruses with probiotics |
| Q90231715 | Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development |
| Q34485266 | Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production |
| Q34702360 | Norovirus P particle efficiently elicits innate, humoral and cellular immunity |
| Q36445296 | Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus |
| Q41500656 | Norovirus infections and seroprevalence of genotype GII.4-specific antibodies in a Spanish population. |
| Q36078623 | Norovirus recognition sites on histo-blood group antigens |
| Q36275589 | Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives |
| Q38081967 | Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis |
| Q36876480 | Norovirus-host interaction: implications for disease control and prevention |
| Q47250874 | Norovirus-like VP1 particles exhibit isolate dependent stability profiles. |
| Q37706587 | Norwalk virus-like particles as vaccines |
| Q36792270 | Polyvalent complexes for vaccine development |
| Q40102851 | Prospects and Challenges in the Development of a Norovirus Vaccine |
| Q90043367 | Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens |
| Q35076817 | Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. |
| Q21089614 | Rapid evolution of pandemic noroviruses of the GII.4 lineage |
| Q37517465 | Recent Advances in the Discovery of Norovirus Therapeutics |
| Q38819439 | Recent advancements in combination subunit vaccine development |
| Q41841490 | Secreted production of assembled Norovirus virus-like particles from Pichia pastoris |
| Q35943850 | Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner |
| Q38301692 | Strain-specific interaction of a GII.10 Norovirus with HBGAs |
| Q27650214 | Structural Basis for the Receptor Binding Specificity of Norwalk Virus |
| Q27671068 | Structural Basis for the Recognition of Lewis Antigens by Genogroup I Norovirus |
| Q64063758 | Structural Basis of Nanobodies Targeting the Prototype Norovirus |
| Q58546290 | Structural adaptations of norovirus GII.17/13/21 lineage through two distinct evolutionary paths |
| Q24682901 | Structural basis for the recognition of blood group trisaccharides by norovirus |
| Q102135811 | Structural heterogeneity of a human norovirus vaccine candidate |
| Q33812653 | Subviral particle as vaccine and vaccine platform |
| Q34724844 | Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles |
| Q64947514 | The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics. |
| Q46111610 | The carbohydrate moiety and high molecular weight carrier of histo-blood group antigens are both required for norovirus-receptor recognition |
| Q83274630 | The formation of P particle increased immunogenicity of norovirus P protein |
| Q35819128 | Tulane virus recognizes sialic acids as cellular receptors |
| Q34615059 | Two gastroenteritis outbreaks caused by GII Noroviruses: host susceptibility and HBGA phenotypes |
| Q33578075 | Vaccine against norovirus |
| Q38866617 | Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection |
Search more.